Clinical Trial Update: Treatment Efficacy and Safety of TDF-TAF Switch Study in South Korea

View source ↗

Summary

A South Korea trial is evaluating switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in chronic hepatitis B patients, assessing e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Chronic Hepatitis b | Status: UNKNOWN